Status: current, Defined. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4824441000168114 | Rybrevant (amivantamab 350 mg / 7 mL) injection, 1 x 7 mL vial (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4824451000168111 | Rybrevant 350 mg/7 mL injection, 7 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Rybrevant 350 mg/7 mL injection, 7 mL vial | Is a | amivantamab 350 mg/7 mL injection, 7 mL vial | true | Inferred relationship | Some | ||
| Rybrevant 350 mg/7 mL injection, 7 mL vial | Is a | trade product pack | true | Inferred relationship | Some | ||
| Rybrevant 350 mg/7 mL injection, 7 mL vial | has TP | Rybrevant | true | Inferred relationship | Some | ||
| Rybrevant 350 mg/7 mL injection, 7 mL vial | has TPUU | Rybrevant 350 mg/7 mL injection, 7 mL vial | true | Inferred relationship | Some | 1726020021 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Rybrevant 350 mg/7 mL injection, 7 mL vial | Is a | True | Rybrevant 350 mg/7 mL injection, 7 mL vial | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR